Skip to content

HoLEP vs BPRP in the Management of a Large Volume (> 80 gm) Symptomatic BPH

Holmium Laser Enucleation Versus Bipolar Resection in the Management of a Large Volume (> 80 gm) Symptomatic BPH: a Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04935151
Enrollment
112
Registered
2021-06-22
Start date
2016-12-04
Completion date
2021-03-10
Last updated
2021-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BPH With Urinary Obstruction, Male

Keywords

BPH, enucleation, Large Prostate, LUTS, IPSS, quality of life

Brief summary

To compare bipolar resection versus holmium laser enucleation for management of symptomatic large BPH (\> 80 gm)

Detailed description

To compare safety and efficacy of bipolar resection (BPRP) versus holmium laser enucleation (HoLEP) for management of symptomatic large BPH (\> 80 gm)

Interventions

cystoscopic transurethral enucleation of the prostate using Holmium laser

cystoscopic transurethral resection of the prostate using bipolar energy

Sponsors

Theodor Bilharz Research Institute
CollaboratorOTHER
Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients suffering from LUTS secondary to infravesical obstruction from BPH with failed medical treatment * International Prostate Symptom Score (IPSS) \> 13 * a peak urinary flow rate (Qmax) \< 15 ml/sec * a prostate size ≥ 80 gm

Exclusion criteria

* presence of a urethral stricture * neurological disorder * bladder cancer * prostate cancer * previous history of bladder neck surgery or TURP

Design outcomes

Primary

MeasureTime frameDescription
hemoglobin drop postoperatively (gm/dL)within two hours after surgerychange in hemoglobin concentration postoperatively vs preoperatively

Secondary

MeasureTime frameDescription
operative duration in minutesTime lapsed during surgeryoperative duration
Hospital stayFrom time of randomisation up to last day of admission in hospital (in days) up to 30 daysHospitalisation starting from day of surgery till the day of discharge from Hospital in days
blood transfusionduring surgery and hospitalisation up to 10 daysrate of blood transfusion

Other

MeasureTime frameDescription
complications (percent)Three yearsAll complications
International prostate symptom score (IPSS)Three yearsan international commonly used score ranging from 0 - 35 (the worst is 35) evaluating voiding and storage urinary symptoms using 7 questions each one is scored from 0 to 5 according to severity of symptom
Quality of life (QoL)Three yearssection of International prostate symptom score (IPSS) one question scored from 0 up to 6 (6 is worst)
flowmetryThree yearsrate of flow (ml urine) per second

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026